Inhibitors of the mTOR signaling pathway can play an important role in breast cancer immunopathogenesis.

MLA

Al, Hawary, Sulieman I.Shelash, et al. “Inhibitors of the MTOR Signaling Pathway Can Play an Important Role in Breast Cancer Immunopathogenesis.” Cell Biology International, vol. 48, no. 11, Nov. 2024, pp. 1601–11. EBSCOhost, https://doi.org/10.1002/cbin.12231.

APA

Al, H. S. I. S., Altalbawy, F. M. A., Jasim, S. A., Jyothi S, R., Jamal, A., Naiyer, M. M., Mahajan, S., Kalra, H., Jawad, M. A., & Zwamel, A. H. (2024). Inhibitors of the mTOR signaling pathway can play an important role in breast cancer immunopathogenesis. Cell Biology International, 48(11), 1601–1611. https://doi.org/10.1002/cbin.12231

Chicago

Al, Hawary, Sulieman I. Shelash, Farag M. A. Altalbawy, Saade Abdalkareem Jasim, Renuka Jyothi S, Azfar Jamal, Mohammed M. Naiyer, Shriya Mahajan, Hitesh Kalra, Mohammed Abed Jawad, and Ahmed Hussein Zwamel. 2024. “Inhibitors of the MTOR Signaling Pathway Can Play an Important Role in Breast Cancer Immunopathogenesis.” Cell Biology International 48 (11): 1601–11. doi:10.1002/cbin.12231.